Allen Baharaff - 31 Dec 2024 SCHEDULE 13G/A Report for Galmed Pharmaceuticals Ltd. Ordinary shares, NIS 1.80 par value per share (GLMD)

Filing Manager: Allen Baharaff
Reporting Manager: Allen Baharaff
Security: Galmed Pharmaceuticals Ltd. Ordinary shares, NIS 1.80 par value per share
Symbol: GLMD
Shares outstanding: 1,697,231 shares
Disclosed Ownership: 44,128 shares
Ownership: 2.6%
Form type: SCHEDULE 13G/A
Filing time: 18 Feb 2025, 16:15:05 UTC
Date of event: 31 Dec 2024
SEC: View on sec.gov

Reporting Managers (1)

Name	Ownership	Shares Owned	sole voting power	shared voting power	Signature	Title	CIK
Allen Baharaff	2.6%	44,128	44,128	0	/s/ Allen Baharaff	Allen Baharaff